Gunasekaran, P.; Shin, S.C.; Hwang, Y.S.; Lee, J.; La, Y.K.; Yim, M.S.; Kim, H.N.; Kim, T.W.; Yang, E.; Lee, S.J.;
et al. N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer. Pharmaceutics 2025, 17, 1027.
https://doi.org/10.3390/pharmaceutics17081027
AMA Style
Gunasekaran P, Shin SC, Hwang YS, Lee J, La YK, Yim MS, Kim HN, Kim TW, Yang E, Lee SJ,
et al. N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer. Pharmaceutics. 2025; 17(8):1027.
https://doi.org/10.3390/pharmaceutics17081027
Chicago/Turabian Style
Gunasekaran, Pethaiah, Sang Chul Shin, Yeon Sil Hwang, Jihyeon Lee, Yeo Kyung La, Min Su Yim, Hak Nam Kim, Tae Wan Kim, Eunjung Yang, Soo Jae Lee,
and et al. 2025. "N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer" Pharmaceutics 17, no. 8: 1027.
https://doi.org/10.3390/pharmaceutics17081027
APA Style
Gunasekaran, P., Shin, S. C., Hwang, Y. S., Lee, J., La, Y. K., Yim, M. S., Kim, H. N., Kim, T. W., Yang, E., Lee, S. J., Yoon, J. M., Kim, E. E., Jeon, S., Ryu, E. K., & Bang, J. K.
(2025). N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer. Pharmaceutics, 17(8), 1027.
https://doi.org/10.3390/pharmaceutics17081027
